Post marketing studies, often referred to as Phase IV clinical trials, are conducted after a pharmaceutical product has received regulatory approval and is available on the market. These studies are crucial for monitoring the long-term effectiveness and safety of new drugs and vaccines in the general population. They provide valuable data on the potential adverse effects, drug interactions, and overall impact on public health.
